Pancreatic Cysts.
Pancreatic cysts are more common than before, largely because of widespread abdominal imaging. Pancreatic cystic neoplasms (PCN) are relevant to risk selection on 2 counts: they constitute more than 50% of all pancreatic cysts and, in contrast to the other 2 cyst types, are capable of malignant transformation. The majority of PCNs are benign at time of diagnosis and will follow a benign course. The challenge is to identify those PCNs that are malignant or will undergo malignant transformation with time. The purpose of this article is to provide pointers that can help meet this challenge while also summarizing the ongoing debate about their optimal management.
Meagher: Vice-President and Medical Director, Munich Re, Montreal; Associate Professor of Medicine, McGill University, Montréal, Québec; Armuss: Medical Officer, Munich Re, Munich, Germany.
Timothy
T
Meagher
Meagher: Vice-President and Medical Director, Munich Re, Montreal; Associate Professor of Medicine, McGill University, Montréal, Québec; Armuss: Medical Officer, Munich Re, Munich, Germany.
Andreas
A
Armuss
D003937:Diagnosis, Differential; D006801:Humans; D010181:Pancreatic Cyst / Q000175:diagnosis / Q000628:therapy; D010190:Pancreatic Neoplasms
Pancreas; life insurance; mortality.; pancreatic cysts